VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
VRPX
Delisted
VRPX was delisted on the 3rd of April, 2025.
15 hedge funds and large institutions have $121K invested in Virpax Pharmaceuticals, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$16K | |
| 2 | +$5.59K | |
| 3 | +$3.74K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.12K |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.37K |